Explore our strategy and projects
to learn about the future of our company
Results FY 2023 (€/MLN)
1,148
Revenues
375
Adjusted EBITDA
224
Adjusted net profit
209
Free cash flow
2023 Investor Day: Diasorin 3.0
On December 15, 2023 Diasorin Management Team presented the new Business Plan.
Keep
in touch
Sign up for our investor alerts
and stay informed
on the latest developments